Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis; dysregulation of this axis causes diabetes. PGC-1α (peroxisome-proliferator-activated receptor-γ coactivator-1α) links insulin signalling to the expression of glucose and lipid metabolic genes. The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1α and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1α. Although insulin is a mitogenic signal in proliferative cells, whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1-cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1α acetylation. Insulin/GSK-3β (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1α activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1-Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, CDK4 phosphorylation of GCN5 can lead to acetylation of PGC-1α and is associated with decreased glucose metabolism in hepatic cells (Lee et al., 2014).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Lee et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 1×
“CDK4 regulates G1 to S phase transition and its kinase activity is dependent on its binding to one of the three D-type cyclins including cyclin D1 13 .”
BackgroundNutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Self-citationReplication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194 · cited 1×
“Interestingly, genome-wide association studies have revealed that mutations of CDKN2A, a CDK4 inhibitor, are significantly correlated with a high risk of type 2 diabetes 27 .”
BackgroundGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“GSK3 β , active during fasting and inactive during refeeding due to its phosphorylation by insulin-AKT signaling, negatively regulates cyclin D1 through phosphorylation of T286, causing nuclear exclusion of cyclin D1 and proteasomal degradation 19,22 .”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Self-citation(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236 · cited 1×
“PD 0332991, the most specific CDK4 inhibitor available 15 , led to a similar decrease of PGC-1 α acetylation (Fig.”
BackgroundMatsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 2×
“…of CKD4 activity by cyclin D1 wild-type overepxression or Cyclin D1 T286A mutant, a hyperactive mutant allele spared from proteasomal degradation 19 , but not cyclin D1 K112E (a mutant that cannot activate CDK4 kinase activity 18 ), suppressed gluconeogenic genes and glucose production,…”
Background
Cited by
Items 101–200 of 254
Sante, G. D., Pagé, J., Jiao, X., Nawab, O., Cristofanilli, M., Skordalakes, E., & Pestell, R. G. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1615889 · Cited by 34
Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation
Scruggs, A. M., Koh, H. B., Tripathi, P., Leeper, N. J., White, E. S., & Huang, S. K. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0298oc · Cited by 33
Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells
Walter, W., Thomalla, J., Bruhn, J., Fagan, D. H., Zehowski, C., Yee, D., & Skildum, A. J. (2015) · SpringerPlus · doi:10.1186/s40064-015-1444-2 · Cited by 33
Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors
Hawash, M. (2024) · Cells · doi:10.3390/cells13191656 · Cited by 32
Emerging innovative treatment strategies for advanced clear cell renal cell carcinoma
Choi, S. H., Chen, Y., Panian, J. A., Yuen, K., & McKay, R. R. (2024) · The Oncologist · doi:10.1093/oncolo/oyae276 · Cited by 31
Chatterboxes: the structural and functional diversity of cyclins
Tatum, N. J., & Endicott, J. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.021 · Cited by 31
Yu, X., Pang, L., Yang, T., & Liu, P. (2018) · Oncology Reports · doi:10.3892/or.2018.6674 · Cited by 31
Nuclear Receptor Coregulators in Metabolism and Disease
Giudici, M., Goñi, S., Fan, R., & Treuter, E. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_5 · Cited by 30
Itkonen, H. M., Poulose, N., Walker, S., & Mills, I. G. (2019) · Neoplasia · doi:10.1016/j.neo.2019.05.001 · Cited by 30
Cheng, N.-M., Fang, Y.-H. D., Tsan, D., Lee, L., Chang, J. T., Wang, H., Ng, S., Liao, C.-T., Yang, L., & Yen, T. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.01.030 · Cited by 30
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
Sager, R., Backe, S. J., Ahanin, E. F., Smith, G., Nsouli, I. S., Woodford, M. R., Bratslavsky, G., Bourboulia, D., & Mollapour, M. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00571-8 · Cited by 29
Gassaway, B. M., CARDONE, R. L., Padyana, A. K., Petersen, M. C., Judd, E. T., Hayes, S., Tong, S., Barber, K. W., Apostolidi, M., Abulizi, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.009 · Cited by 29
Self-citationCoroglaucigenin induces senescence and autophagy in colorectal cancer cells
Huang, Y., Lei, J., Yi, G., Huang, F., Li, Y., Wang, C., Sun, Y., Dai, H., & Tan, G. (2018) · Cell Proliferation · doi:10.1111/cpr.12451 · Cited by 29
MicroRNA-16 modulates macrophage polarization leading to improved insulin sensitivity in myoblasts
Talari, M., Kapadia, B. B., Kain, V., Seshadri, S., Prajapati, B., Rajput, P., Misra, P., & Parsa, K. V. L. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.004 · Cited by 29
Emerging role of GCN5 in human diseases and its therapeutic potential
Xiao, H., Jin, J., & Zheng, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114835 · Cited by 29
Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia
Blachly, J. S., Byrd, J. C., & Grever, M. R. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.02.003 · Cited by 29
A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition
Kaulich, M., Link, V. M., Lapek, J. D., Lee, Y. J., Glass, C. K., Gonzalez, D. J., & Dowdy, S. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-94200-w · Cited by 28
Self-citationFascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK
Oh, T.-I., Lee, J. H., Kim, S., Nam, T.-J., Kim, Y. S., Kim, B. M., Yim, W. J., & Lim, J.-H. (2017) · Molecules · doi:10.3390/molecules23010042 · Cited by 27
Self-citationCyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation
Knight, H., Abis, G., Kaur, M., Green, H. L. H., Krasemann, S., Hartmann, K., Lynham, S., Clark, J. E., Zhao, L., Ruppert, C., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321836 · Cited by 27
CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged Rats
Sacaan, A. I., Thibault, S., Hong, M., Kondegowda, N. G., Nichols, T., Li, R., Rosselot, C., Evering, W., Fenutría, R., Vitsky, A., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0172 · Cited by 25
Chen, X., Wang, L., Hong, L., Su, Z., Zhong, X., Zhou, H., Zhang, X., Wu, J., & Shao, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.661988 · Cited by 24
Wu, H., Ploeger, J. M., Kamarajugadda, S., Mashek, D. G., Mashek, M. T., Manivel, J. C., Shekels, L. L., Lapiro, J. L., & Albrecht, J. H. (2019) · Hepatology Communications · doi:10.1002/hep4.1316 · Cited by 24
Liu, T., Wang, Y., Wang, Y., Cheung, S. K.-K., Or, P. M. Y., Wong, C.-W., Guan, J., Li, Z., Yang, W., Tu, Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215914 · Cited by 24
Yang, C.-H., Mangiafico, S. P., Waibel, M., Loudovaris, T., Loh, K., Thomas, H. E., Morahan, G., & Andrikopoulos, S. (2020) · Diabetologia · doi:10.1007/s00125-020-05137-0 · Cited by 23
Regulation of Hepatic Metabolism, Recent Advances, and Future Perspectives
Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1224-4 · Cited by 23
Self-citationMa, Y., Zhu, Q., Liang, J., Li, Y., Li, M., Zhang, Y., Wang, X., Zeng, Y., & Jiao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0203-1 · Cited by 23
The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis
Aldaalis, A., Bengoechea-Alonso, M. T., & Ericsson, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.942386 · Cited by 23
APC/C-CDH1–Regulated IDH3β Coordinates with the Cell Cycle to Promote Cell Proliferation
Wu, Q., Zhang, W., Xue, L., Wang, Y., Fu, M., Ma, L., Song, Y., & Zhan, Q.-M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2341 · Cited by 22
What programs the size of animal cells?
Liu, S., Tan, C., Tyers, M., Zetterberg, A., & Kafri, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.949382 · Cited by 22
Belapurkar, R., Pfisterer, M., Dreute, J., Werner, S., Zukunft, S., Fleming, I., Kracht, M., & Schmitz, M. L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06012-7 · Cited by 22
Bahn, Y. J., Yadav, H., Piaggi, P., Abel, B. S., Gavrilova, O., Springer, D., Papazoglou, I., Zerfas, P. M., Skarulis, M. C., McPherron, A. C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162479 · Cited by 22
DHA Suppresses Hepatic Lipid Accumulation via Cyclin D1 in Zebrafish
Ding, Q., Hao, Q., Zhang, Q., Yang, Y., Olsen, R. E., Ringø, E., Ran, C., Zhang, Z., & Zhou, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.797510 · Cited by 22
Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency
Luo, C., Liang, J., Sharabi, K., Hatting, M., Perry, E. A., Tavares, C. D. J., Goyal, L., Srivastava, A., Bilodeau, M., Zhu, A. X., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0106 · Cited by 22
Self-citationLiu, W., Hu, M., Wang, Y., Sun, B., Guo, Y., Xu, Z., Li, J., & Han, B. (2015) · Oncology Reports · doi:10.3892/or.2015.3724 · Cited by 22
Mariano, F. V., Giovanetti, K., Saccomani, L. F. V., Negro, A. D., Kowalski, L. P., Krepischi, A. C. V., & ALTEMANI, A. M. D. A. M. (2016) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2015.12.004 · Cited by 22
Breaking Cancer’s Momentum: CDK4/6 Inhibitors and the Promise of Combination Therapy
Liu, Y., Park, S., & Li, Y. (2025) · Cancers · doi:10.3390/cancers17121941 · Cited by 21
Regulators of carcinogenesis: Emerging roles beyond their primary functions
Jia, L., Zhang, R., Shen, L., & Yang, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.048 · Cited by 19
Hepatic Gadd45β promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1α
Wu, L., Jiao, Y., Li, Y., Jiang, J., Zhao, L., Li, M., Li, B., Yan, Z., Chen, X., Li, X., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201475 · Cited by 19
Wang, X., Wang, C., Yan, G., Kang, Y., Sun, G., Wang, S., Zou, R., Sun, H., Zeng, K., Song, H., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102685 · Cited by 19
Giannattasio, S., Giacovazzo, G., Bonato, A., Caruso, C., Luvisetto, S., Coccurello, R., & Caruso, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31090-5 · Cited by 18
Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21
Mortoglou, M., Miralles, F., Mould, R. R., Sengupta, D., & Onganer, P. U. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151318 · Cited by 18
Endaya, B., Guan, S. P., Newman, J. P. A., Huynh, H. T., Sia, K. C., Chong, S. T., Kok, C. Y. L., Chung, A. Y. F., Liu, B. B., Hui, K. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17633 · Cited by 17
Huang, S., Dong, X., Wang, J., Ding, J., Li, Y., Li, D., Lin, H., Wang, W., Zhao, M., Chang, Q., et al. (2018) · Medical Science Monitor · doi:10.12659/msm.909621 · Cited by 17
Bidirectional regulation of genistein on the proliferation and differentiation of C2C12 myoblasts
Gan, M., Yang, D., Fan, Y., Du, J., Shen, L., Li, Q., Jiang, Y., Tang, G., Li, M., Wang, J., et al. (2020) · Xenobiotica · doi:10.1080/00498254.2017.1409917 · Cited by 16
Cho, D.-Y., Han, J., Kim, I. S., Lim, J.-H., Ko, H. M., Kim, B.-W., & Choi, D. (2025) · Science Signaling · doi:10.1126/scisignal.adp8973 · Cited by 16
Self-citationSdao, S. M., Ho, T., Poudel, C., Foster, H. R., Leon, E. R. D., Adams, M. T., Lee, J.-H., Blum, B., Rane, S. G., & Merrins, M. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108690 · Cited by 15
Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone Regulation.
Núñez, K., Gonzalez-Rosario, J., Thevenot, P., & Cohen, A. J. (2017) · PubMed Central · Cited by 15
Hao, Q., Zheng, A., Zhang, H., & Cao, H. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01493-1 · Cited by 15
Cyclin D1 extensively reprograms metabolism to support biosynthetic pathways in hepatocytes
Wu, H., Kren, B. T., Lane, A. N., Cassel, T., Higashi, R. M., Fan, T. W. ‐., Scaria, G. S., Shekels, L. L., Klein, M. A., & Albrecht, J. H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105407 · Cited by 14
Posttranslational regulation of the GCN5 and PCAF acetyltransferases
Ononye, O. E., & Downey, M. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010352 · Cited by 14
Postmitotic G1 phase survivin drives mitogen-independent cell division of B lymphocytes
Singh, A., Spitzer, M. H., Joy, J. P., Kaileh, M., Qiu, X., Nolan, G. P., & Sen, R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115567119 · Cited by 14
Posttranslational modifications in diabetes: Mechanisms and functions
Hu, A., Zou, H., Chen, B., & Zhong, J. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09740-x · Cited by 14
Song, X., Liao, X.-Y., Zheng, X., Liu, J., Zhang, Z.-W., Zhang, L., & Yan, Y. (2021) · Cancers · doi:10.3390/cancers13040834 · Cited by 14
Chong, Y. K., Tartey, S., Yoshikawa, Y., Imami, K., Li, S., Yoshinaga, M., Hirabayashi, A., Liu, G., Vandenbon, A., Hia, F., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abm5011 · Cited by 13
In Silico Prediction of the Mode of Action of Viola odorata in Diabetes
Buabeid, M. A., Arafa, E. A., Hassan, W., & Murtaza, G. (2020) · BioMed Research International · doi:10.1155/2020/2768403 · Cited by 13
Targeting PKLR in liver diseases
Yuan, M., Shi, M., Yang, H., Ashraf, S., Iqbal, S., Türkez, H., Borén, J., Zhang, C., Uhlén, M., Altay, Ö., et al. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.009 · Cited by 12
TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion
Hsieh, J., Molusky, M. M., McCabe, K. M., Fotakis, P., Xiao, T., Tascau, L., Zeana-Schliep, L., DaSilva-Jardine, P. A., & Tall, A. R. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.021 · Cited by 12
Non‐Cell Cycle Functions of the CDK Network in Ciliogenesis: Recycling the Cell Cycle Oscillator
Krasińska, L., & Fisher, D. (2018) · BioEssays · doi:10.1002/bies.201800016 · Cited by 12
Wei, X., Zhou, J., Hong, L., Xu, Z., Zhao, H., Wu, X., & Chen, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.8900 · Cited by 12
Yang, E., Gavini, K., Bhakta, A., Dhanasekaran, M., Khan, I. A., & Parameshwaran, K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.019 · Cited by 11
Peng, C. C., Chen, E. C. Y., Chen, C., Chyau, C.-C., Chen, K., & Peng, R. Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306575 · Cited by 11
Cong, M. H., Wen, L., Han, F., Xu, Y., & Shi, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7613 · Cited by 11
Ran, M., Luo, H., Gao, H., Tang, X., Yao, C., Zeng, X., Weng, B., & Chen, B. (2020) · Reproduction in Domestic Animals · doi:10.1111/rda.13626 · Cited by 11
Sheet, S., Srikanth, K., Cha, J., Choi, S., & Choi, B. (2020) · Animals · doi:10.3390/ani10112071 · Cited by 10
Guo, X., Zhang, W., Ren, J., Chen, Y., Wang, J., Zhu, C., Zhang, Y., & Gao, A. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.07.004 · Cited by 10
Guo, T., Li, B., Gu, C., Chen, X., Han, M., Liu, X., & Xu, C. (2019) · Aging · doi:10.18632/aging.102082 · Cited by 10
Exercise Partially Rejuvenates Muscle Stem Cells
Larrick, J. W., & Mendelsohn, A. R. (2020) · Rejuvenation Research · doi:10.1089/rej.2020.2359 · Cited by 9
Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions
Klein, M. A. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.11.009 · Cited by 9
Núñez, K., Frank, A. R., Gonzalez-Rosario, J., Galliano, G. E., Bridle, K. R., Crawford, D. H., Seal, J. B., Abbruscato, F. C., Vashistha, H., Thevenot, P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216242 · Cited by 9
CDK4, a new metabolic sensor that antagonizes AMPK
Fajas, L., & López‐Mejía, I. C. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1409862 · Cited by 8
Zhang, J., Zhao, Y., Pulivendala, G., Zhang, Q., Rui, L., Gao, J., Wang, H., Zhang, G., Nuotio-Antar, A. M., Tong, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202415032 · Cited by 8
Herrera, E. L., Azzam, S. Z., Berger, M. C., & Díaz-Martínez, L. A. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.35 · Cited by 8
Lyakhova, I., Piatkova, M. A., Khotimchenko, Y. S., Zhidkov, M. E., Kantemirov, A. V., Khotimchenko, R., Bryukhovetskiy, A. S., Sharma, A., Sharma, H. S., & Bryukhovetskiy, I. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.011 · Cited by 8
Long, F., Zhang, Z., Luo, C., Lei, X., Guo, J., & An, L. (2023) · Medicine · doi:10.1097/md.0000000000033210 · Cited by 7
Liu, Y., Liu, Q., Wang, Z., Chen, M., Chen, Y., Li, X., Huang, D., Fan, S., Xiong, W., Li, G., et al. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23298 · Cited by 7
Cell cycle period control through modulation of clock inputs
Almeida, S., Chaves, M., & Delaunay, F. (2020) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720020400065 · Cited by 6
von Wichert, L., Stroh, A., Witt, M., Wanzel, M., Mernberger, M., Griewing, S., Wündisch, T., Pfitzner, B. M., Teply‐Szymanski, J., Litmeyer, A., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08496-5 · Cited by 5
CDK6: an attractive therapeutic target for T-ALL/LBL
Li, W., Hu, J. K., & Hu, M. G. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2285775 · Cited by 5
Maternal obesity attenuates PPARγ nuclear migration impairing offspring adipogenesis
de Sousa, É., & Rodrigues, A. C. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0050 · Cited by 5
Okada, Y., Chikura, S., Kimoto, T., & Iijima, T. (2024) · Genes and Environment · doi:10.1186/s41021-024-00298-5 · Cited by 5
Priyadharshini, R. D., Jeyashree, R., Preethi, R., Vennila, K. N., & Elango, K. P. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2212787 · Cited by 5
Structural requirements for the specific binding of CRABP2 to cyclin D3
Pastok, M. W., Tomlinson, C. W. E., Turberville, S., Butler, A. M., Baslé, A., Noble, M. E. M., Endicott, J., Pohl, E., & Tatum, N. J. (2024) · Structure · doi:10.1016/j.str.2024.09.020 · Cited by 4
Mammalian Development and Cancer: A Brief History of Mice Lacking D-Type Cyclins or CDK4/CDK6
Kalaszczyńska, I., & Ciemerych, M. A. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_2 · Cited by 4
Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation
Stamateris, R. E., Sharma, R. B., Landa-Galván, H. V., Darko, C., Redmond, D., Rane, S. G., & Alonso, L. C. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166490 · Cited by 4
Citrate oscillations during cell cycle are a targetable vulnerability in cancer cells
Icard, P., Alifano, M., & Simula, L. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189313 · Cited by 4
D-Type Cyclins and Gene Transcription
Sante, G. D., Casimiro, M. C., Li, Z., Ertel, A., Tompa, P., & Pestell, R. G. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_3 · Cited by 4
HDAC1 deacetylates PGC-1α and its inhibition improves glucose homeostasis in diet-induced obese mice
Fainshtein, C. A., Maalumi, O., De-Leon, K.-E., Barkan-Michaeli, R., & Sharabi, K. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00399.2024 · Cited by 4
Bacterial production and structure-function validation of a recombinant glucagon peptide
Yoon, K.-H., Lee, S., Lee, Y.-M., Lee, K., Park, S., Choi, S.-M., Lin, Y., Lim, J.-H., Bang, J. K., Kim, E., et al. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.01.012 · Cited by 4
Self-citationGonzales, K. A. U., & Liang, H. (2015) · Genomics Data · doi:10.1016/j.gdata.2015.08.032 · Cited by 4
Almeida, S. J. F. (2018) · theses.fr (ABES) · doi:10.70675/d7f43940zfb09z447az8fcez09de3d68881f · Cited by 3
Barquissau, V., Zanou, N., Geller, S., Castillo‐Armengol, J., Marzetta, F., Huber, K., Ziegler, D. V., López‐Mejía, I. C., Fernandez, J. B., Roger, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.03.482783 · Cited by 3
Han, B., Li, G. X., Liew, W. L., Chan, E., Huang, S., Khoo, C. M., Leow, M. K., Lee, Y. S., Zhao, T., Wang, L. C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.30.547176 · Cited by 3
Self-citationEffect and mechanism of mGluR6 on the biological function of rat embryonic neural stem cells
Zhang, J., Zhang, L., Chen, Y., Shi, H., Huang, X., Wang, Y., Wang, Y., Wei, Y., Xue, W., & Han, J. (2019) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2019.1578639 · Cited by 3
Vlad-Fiegen, A., Freytag, N. V., Dorn, S. B., Müller, O., & Eberth, S. (2016) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2016.412017 · Cited by 3
GINS1 facilitates the development of lung adenocarcinoma via Wnt/β-catenin activation
Ma, L., Li, R., Li, P., Yu, W., Tang, Z., Si, L., & Tian, H. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03786-2 · Cited by 3
Cyclin D1, Metabolism, and the Autophagy-Senescence Balance
Valenzuela, C. A., & Brown, N. E. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_5 · Cited by 2
Chetina, E. V., Demidova, N. V., & Markova, G. A. (2019) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2019-2-47-54 · Cited by 2
Hyper sensitive protein detection by Tandem-HTRF reveals Cyclin D1 dynamics in adult mouse
Zampieri, A., Champagne, J., Auzemery, B., Fuentes, I., Maurel, B., & Bienvenu, F. (2015) · Scientific Reports · doi:10.1038/srep15739 · Cited by 2
Zapater, A. G., Kourtis, S., Elbæk, C. R., Espinar, L., Toro‐Márquez, C., Coll‐Manzano, A., Smiriglia, A., García‐López, L., Wiegand, L., Guirola, M., et al. (2026) · Advanced Science · doi:10.1002/advs.202501083 · Cited by 2
The Prevention, Treatment, and Complications of Diabetes Mellitus
(2023) · MDPI eBooks · doi:10.3390/books978-3-0365-9545-0 · Cited by 2
Metadata
- Authors
- Lee, Y., Dominy, J. E., Choi, Y. J., Jurczak, M., Tolliday, N., Camporez, J. P., Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., Vazquez, F., Sicinski, P., Shulman, G. I., & Puigserver, P.
- Affiliations
- Harvard University (US)
- Yale University (US)
- Broad Institute (US)
- Corresponding author
- Puigserver, Pere
- ORCID
- Venue
- Nature
- Published
- 2014-05-25
- Volume
- 510
- Issue
- 7506
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4076706
- OpenAlex
- W2095720556
- Cited by
- 234
- References
- 36
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 9 · 2023: 16 · 2022: 15 · 2021: 14 · 2020: 29 · 2019: 28 · 2018: 26 · 2017: 25 · 2016: 20 · 2015: 20 · 2014: 5
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (2r24dk080261-06a1)
- U.S. Public Health Service (R01 069966)
- National Institute of Mental Health (R03 MH092174)
- National Institute on Drug Abuse (R03DA032468)
- National Cancer Institute (R01CA108420, R01CA083688)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24 DK-080261, R24DK080261-06, R01DK089098, R01DK069966, U24DK059635, F32DK083871, DK059635, P30DK034989)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- cyclin D1, CDK4, insulin signaling, glucose metabolism, gluconeogenesis, PGC-1α, GCN5, histone acetylation, hepatic glucose production, glucose homeostasis, GSK3β, amino acids, diabetes mellitus, CDK4 inhibitors, cell cycle machinery, metabolic disorders
- MeSH terms
- Glycogen Synthase Kinase 3 beta, p300-CBP-Associated Factor, Acetylation, Amino Acids, Animals, Cell Cycle, Cell Nucleus, Cells, Cultured, Diabetes Mellitus, Enzyme Activation, Fasting, Gluconeogenesis, Glucose, Homeostasis, Humans, Hyperglycemia, Hyperinsulinism, Insulin, Male, Phosphorylation, RNA, Messenger, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Deletion, Cyclin D1, Hepatocytes, Glycogen Synthase Kinase 3, Cell Line, Tumor, Cyclin-Dependent Kinase 4, Mice, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.